Intravenous immunoglobulin: Another therapeutic application;Inmunoglobulina intravenosa: Una nueva aplicación terapéutica

Nefrologia

Volumn 27, Issue 2, 2007, Pages 214-216

  De Gracia Núñez, Raquel ^a   Jimenez C ^a   Gil, F ^a   Escuin F ^a   Castell, J ^a   Sanz, A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Intravenous inmunoglobulin; Maintenance immunosupressor treatment; Oral intestinal problem; Renal transplant; Septic shock

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION;

ADULT; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION;

EID: 34548397182     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kazatchkine MD, Srini V, Kaveri DVM: Advances in immunology: immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345: 747-755, 2001.
2. Luke PP, Scantlebury VP, Jordan ML, Vivas CA, Hakada TR, Jain A, Somani A: Reversal of steroid and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 72 (3): 419-22, 2001.
3. Casadei D, Del C, Rial M, Opelz G, Goldberg J, Argenteo J, Greco G, Guari O: A randomized and prospective study comparing treatment with hig-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 71 (1): 53-58, 2001.
4. Jordan SC, Vo A, Toyoda M, Moudgil A: Preliminary results from a randomised, blinded, placebo-controlled trial of intravenous gammaglobulin (IVIG) + pulse steroids for the treatment of acute rejection episodes in renal allograft recipient. Transplantation 67 (7) S117, 1999.
5. Peraldi M N, Akposso K, Haymann J P, Flahaut A, Marlin C, Rondeau E, Sraer JD: Long-term benefit of intravenous immunoglobulin in cadaveric Kidney retransplante. Transplantation 62 (11): 1670-1673, 1999.
6. Moger V, Ravishankar MS, Sakhuja V, Kohli HS, Sud K, Gupta KL, Jha V: Intravenous Immunoglobulin: a safe option for treatment of steroid- resistant rejection in the presence of infection. Transplantation 77 (9): 1455-1456, 2004.
7. Tsinalis D, Dickermann M, Brunner F, Gurke L, Mihartsch M, Nickeleit V: Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. Am J Kidney Dis 40 (3) 667-70, 2002.
8. Haas M, Sonnenday CJ, Cicone JS, Rabb H, Montgomery RA: Isometric tubular epithelial vacuolisation in renal allograft biopsy specimens of patient receiving low-dose intravenous immunoglobulin for a positive crossmatch. Transplantation 78 (4): 549-556, 2004.
9. Ahsan N: Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy. J Nephrol 11 (3): 157-61, 1998.
10. Stanley C. Jordan, Dolly Tyan, Don Stablein, Matthew Mcintosh, Steve Rose, Ashley Vo: Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitised adult patients with end-stage renal disease: report of the NIH IG02 Trial. J Am Soc Nephrol 15: 3256-3262, 2004.
11. Jordan SC, Cunningham-Rundles C, McEwan R: Utility of intravenous gammaglobulin in kidney transplantation: efficacy, safety and cost implications. Am J Transplant 3: 653-664, 2003.